Second transurethral resection after ta high-grade bladder tumor: A 4.5-Year period at a single university center

Urologia Internationalis

Volumn 92, Issue 2, 2014, Pages 131-135

  Lazica, David A ^a   Roth, Stephan ^a   Brandt, Alexander S ^a   Böttcher, Stefanie ^a   Mathers, Michael J ^b   Ubrig, Burkhard ^c  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b Urological Ambulatory   (Germany)

^c Augusta Kranken Anstalt   (Germany)

Author keywords

Bladder neoplasms; Outcome; Reoperation

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER SURGERY; BLADDER TUMOR; CANCER GRADING; CANCER RECURRENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SECOND TRANSURETHRAL RESECTIONS OF THE BLADDER; TRANSURETHRAL RESECTION; VERY ELDERLY; BLADDER CANCER; BLADDER TRANSURETHRAL RESECTION; CANCER CHEMOTHERAPY; CANCER STAGING; CYSTECTOMY; DETRUSOR MUSCLE; HISTOLOGY; HUMAN TISSUE; METASTASIS; MULTIPLE CANCER; OUTCOME ASSESSMENT; PRIMARY TUMOR; REOPERATION; INCIDENCE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; URINARY BLADDER NEOPLASMS; UROLOGIC SURGERY; YOUNG ADULT;

MITOMYCIN;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; UROLOGIC SURGICAL PROCEDURES; YOUNG ADULT;

EID: 84900366068     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000353089     Document Type: Article

References (21)

1. Herr HW: The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 1999; 162: 74-76. (Pubitemid 29420883)
2. Brauers A, Buettner R, Jakse G: Second resection and prognosis of primary high-risk superficial bladder cancer: is cystectomy often too early? J Urol 2001; 165: 808-810. (Pubitemid 32156283)
3. Babjuk M: Transurethral resection of nonmuscle-invasive bladder cancer. Eur Urol Suppl 2009; 8: 542-548.
4. Divrik RT, Sahin AF, Yildirim U, Altok M, Zorlu F: Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial. Eur Urol 2010; 58: 185-190.
5. Grimm MO, Steinhoff C, Simon X, Spiegelhalder P, Ackermann R, Vogeli TA: Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol 2003; 170: 433-437. (Pubitemid 36870218)
6. Kulkarni GS, Hakenberg OW, Gschwend JE, Thalmann G, Kassouf W, Kamat A, Zlotta A: An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer. Eur Urol 2010; 57: 60-70.
7. Dalbagni G, Herr HW, Reuter VE: Impact of a second transurethral resection on the staging of T1 bladder cancer. Urology 2002; 60: 822-825.
8. Yucel M, Hatipoglu NK, Atakanli C, Yalcinkaya S, Dedekarginoglu G, Saracoglu U, Aras E: Is repeat transurethral resection effective and necessary in patients with T1 bladder carcinoma? Urol Int 2010; 85: 276-280.
9. Herr HW: Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome. J Urol 2000; 163: 60-61.
10. Sylvester RJ, van der Meijden A, Witjes JA, Jakse G, Nonomura N, Cheng C, Torres A, Watson R, Kurth KH: High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder. Urology 2005; 66(suppl 1):90-107. (Pubitemid 43049611)
11. Peretsman S: Editorial comment to Herr: Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome. J Urol 2000; 163: 61-62.
12. Huang J, Fu J, Zhan H, Xie K, Liu B, Yang F, Lu Y, Zhou X: Analysis of the absence of the detrusor muscle in initial transurethral resected specimens and the presence of residual tumor tissue. Urol Int 2012; 89: 319-325.
13. Klan R, Loy V, Huland H: Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol 1991; 146: 316-318.
14. Schips L, Augustin H, Zigeuner RE, Galle G, Habermann H, Trummer H, Pummer K, Hubmer G: Is repeated transurethral resection justified in patients with newly diagnosed superficial bladder cancer? Urology 2002; 59: 220-223. (Pubitemid 34134518)
15. Zurkirchen MA, Sulser T, Gaspert A, Hauri D: Second transurethral resection of superficial transitional cell carcinoma of the bladder: a must even for experienced urologists. Urol Int 2004; 72: 99-102. (Pubitemid 38223792)
16. Herr HW: Role of re-resection in non-muscle-invasive bladder cancer. ScientificWorld-Journal 2011; 11: 283-288.
17. Brausi M, Collette L, Kurth K, van der Meijden AP, Oosterlinck W, Witjes JA, Newling D, Bouffioux C, Sylvester RJ: Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 2002; 41: 523-531.
18. Kausch I, Sommerauer M, Montorsi F, Stenzl A, Jacqmin D, Jichlinski P, Jocham D, Ziegler A, Vonthein R: Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies. Eur Urol 2010; 57: 595-606.
19. Zhu YP, Shen YJ, Ye DW, Wang CF, Yao XD, Zhang SL, Dai B, Zhang HL, Shi GH: Narrowband imaging flexible cystoscopy in the detection of clinically unconfirmed positive urine cytology. Urol Int 2011; 88: 84-87.
20. Sylvester RJ, Oosterlinck W, van der Meijden AP: A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 2004; 171: 2186-2190. (Pubitemid 38625431)
21. Burger M, Oosterlinck W, Konety B, Chang S, Gudjonsson S, Pruthi R, Soloway M, Solsona E, Sved P, Babjuk M, Brausi MA, Cheng C, Comperat E, Dinney C, Otto W, Shah J, Thurof J, Witjes JA: ICUD-EAU International Consultation on Bladder Cancer 2012: nonmuscle-invasive urothelial carcinoma of the bladder. Eur Urol 2013; 63: 36-44.